MktsMarkets

Apogee Therapeutics, Inc.
NASDAQ: APGEKey statistics
APGE News
Stories mentioning APGE from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 60,819 | 58,444 | 54,178 | 55,703 | 46,387 | 60,229 | 45,714 | 33,206 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 82,772 | 78,056 | 71,278 | 73,165 | 63,096 | 75,881 | 58,686 | 44,122 |
| Operating Income (Loss) | (82,772) | (78,056) | (71,278) | (73,165) | (63,096) | (75,881) | (58,686) | (44,122) |
| Interest Income | 8,740 | 8,731 | 6,318 | 7,141 | 7,840 | 8,681 | 9,668 | 10,306 |
| Interest Expense | ||||||||
| Other Expense | 8,740 | 8,731 | 6,318 | 7,141 | 7,840 | 8,681 | 9,668 | 10,306 |
| Pretax Income | (74,032) | (69,325) | (64,960) | (66,024) | (55,256) | (67,200) | (49,018) | (33,816) |
| Tax Provision | 79.00 | 62.00 | 61.00 | 72.00 | 83.00 | 18.00 | 0.00 | 0.00 |
| Net Income (Loss) | (74,111) | (69,387) | (65,021) | (66,096) | (55,339) | (67,218) | (49,018) | (33,816) |
| Earnings Per Share (Basic) | (1.06) | (1.14) | (1.11) | (1.13) | (0.95) | (1.22) | (0.86) | (0.60) |
| Earnings Per Share (Diluted) | (1.06) | (1.14) | (1.11) | (1.13) | (0.95) | (1.22) | (0.86) | (0.60) |
| Weighted Average Shares Outstanding (Basic) | 69,668 | 60,691 | 58,774 | 58,428 | 58,195 | 55,194 | 56,796 | 56,515 |
| Weighted Average Shares Outstanding (Diluted) | 69,668 | 60,691 | 58,774 | 58,428 | 58,195 | 55,194 | 56,796 | 56,515 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About APGE
Apogee Therapeutics, Inc. (NASDAQ: APGE) is a stock listed on the Nasdaq Stock Market under the ticker symbol APGE. It last traded at $0.0000 (Dec 31, 1969, 7:00 PM ET), down 0.0% on the day. That gives Apogee Therapeutics a market capitalisation of $10.2B.
Over the past 52 weeks APGE has traded between $56.52 and $135.09.
For the quarter ended Mar 31, 2026 it reported a net loss of $74.1M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$74.1M |
| Dec 31, 2025 | — | -$69.4M |
| Sep 30, 2025 | — | -$65.0M |
| Jun 30, 2025 | — | -$66.1M |
From Apogee Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…